Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 18.2 billion as of January 6, 2026. Its market cap has decreased by -21.14% in one year.

Market Cap

18.20B

Enterprise Value

18.05B

Revenue

2.40B

Ranking

n/a

PE Ratio

369.59

Stock Price

11.35

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 18.20B, an increase of 33.48%. That is a compound annual growth rate of 1.92%.

Market Cap History

Date	Market Cap	% Change
Jan 6, 2026	18.20B	4.31%
Dec 31, 2025	17.45B	-9.69%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	395.76B
WuXi AppTec	267.64B
Shenzhen Mindray Bio-Medical Electronics	230.33B
Sichuan Biokin Pharmaceutical	133.40B
Shanghai United Imaging Healthcare	102.91B
Aier Eye Hospital Group	102.07B
Zhangzhou Pientzehuang Pharmaceutical.,	101.83B
Yunnan Baiyao Group Co.,Ltd	101.27B

Market Cap Rankings